FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pietro Quaglino

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Anatomy

Skin

Procedures

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Pietro Quaglino; Paola Savoia; P Fava; Mauro Novelli; M Papini; Renata Ponti; Maria Grazia Bernengo
Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatoses.
C Delfino; G Goteri; V Grandi; A Pileri; Renato Alterini; L Canafoglia; Pietro Quaglino; S Rupoli; N Pimpinelli
Combination treatment in CTCL: the current role of bexarotene.
Maria Grazia Bernengo; Pietro Quaglino
Erythrodermic CTCL: updated clues to diagnosis and treatment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pietro Quaglino (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pietro Quaglino; Paola Savoia; P Fava; Mauro Novelli; M Papini; Renata Ponti; Maria Grazia Bernengo
Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatoses.
Giornale italiano di dermatologia e venereologia : organo ufficiale, Società italiana di dermatologia e sifilografia 2013;148(2):197-201.
2012: C Delfino; G Goteri; V Grandi; A Pileri; Renato Alterini; L Canafoglia; Pietro Quaglino; S Rupoli; N Pimpinelli
Combination treatment in CTCL: the current role of bexarotene.
Giornale italiano di dermatologia e venereologia : organo ufficiale, Società italiana di dermatologia e sifilografia 2012;147(6):573-80.
2012: Maria Grazia Bernengo; Pietro Quaglino
Erythrodermic CTCL: updated clues to diagnosis and treatment.
Giornale italiano di dermatologia e venereologia : organo ufficiale, Società italiana di dermatologia e sifilografia 2012;147(6):533-44.
2012: Simona Osella-Abate; Pietro Quaglino; Carlo Tomasini; Benedetta Ubezio; Ester Berardengo; Maria Grazia Bernengo; Mauro Novelli; Francesca Orso; Daniela Taverna
Expression of AP-2α, AP-2γ and ESDN in primary melanomas: correlation with histopathological features and potential prognostic value.
Journal of dermatological science 2012;68(3):202-4.
2012: Pietro Quaglino; Serena Rupoli; Stefano Titli; Pier Luigi Zinzani; Mauro Alaibac; Giuseppe Alfonso Lombardo; Maria Grazia Bernengo; Emilio Berti; Ugo Bottoni; Piergiacomo Calzavara-Pinton; Angelo Carbone; Paolo Fava; Michele Fimiani; Angela Maria Mamusa; Nicola Pimpinelli
Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
Cancer 2012;118(23):5830-9.
2012: Pietro Quaglino; Emiliano Antiga; Marzia Caproni; Alessandra Comessatti; Paolo Fabbri; T Nardò; Mauro Novelli; Simona Osella-Abate; Renata Ponti; Maria Grazia Bernengo
Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients.
Archives of dermatological research 2012;304(8):639-45.
2012: Paola Savoia; Virginia Caliendo; P Fava; G Macripò; Simona Osella-Abate; Pietro Quaglino; S Ribero; Maria Grazia Bernengo
Disease progression in melanoma patients with negative sentinel lymph node: does false-negative specimens entirely account for this phenomenon?
Journal of the European Academy of Dermatology and Venereology : JEADV 2012;26(2):242-8.
2012: Maria Teresa Fierro; Narcisa Mandras; Federica Marenco; Chiara Merlino; Pierangela Murabito; Mauro Novelli; Pietro Quaglino; Valeria Allizond; Giuliana Banche; Maria Grazia Bernengo; Anna Maria Cuffini
Functional and phenotypical impairment of polymorphonuclear cells in atopic dermatitis: an additional cause for the known susceptibility to infections?.
Dermatology (Basel, Switzerland) 2012;224(4):323-30.
2011: Pietro Quaglino; S Ribero; Anna Sapino; Paola Savoia; Virginia Caliendo; M Grassi; Luigia Macrì; G Macripò; Simona Osella-Abate; Sofia Asioli; Maria Grazia Bernengo
Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: a single centre observational cohort study.
Surgical oncology 2011;20(4):259-64.
2011: Pietro Quaglino; Paola Savoia; Cristiana Di Bello; Federica Mola; Michela Ortoncelli; Anna Peroni; Maria Grazia Bernengo
Adult-onset cutaneous mastocytosis in monozygotic twins.
Journal of the American Academy of Dermatology 2011;65(3):680-1.
2011: Pietro Quaglino; Paola Savoia; Chiara Gado; Federica Marenco; Tiziana Nardò; Mauro Novelli; Simona Osella-Abate; Maria Grazia Bernengo
FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy.
Pigment cell & melanoma research 2011;24(4):734-6.
2011: Pietro Quaglino; Maria Elena Terlizzi; Sara Astegiano; E Barberio; Massimiliano Bergallo; E Buffa; Rossana Cavallo; S Cicchelli; Alessandra Comessatti; Cristina Costa; Mauro Novelli; Renata Ponti; Maria Grazia Bernengo
Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response.
Dermatology (Basel, Switzerland) 2011;223(1):57-67.
2011: Emanuele Cozzani; Giovanni Di Zenzo; Valentina Calabresi; Marzia Caproni; Donatella Schena; Pietro Quaglino; Angelo V Marzano; Paolo Fabbri; Alfredo Rebora; Aurora Parodi
Anti-desmoplakin antibodies in erythema multiforme and Stevens-Johnson syndrome sera: pathogenic or epiphenomenon?
European journal of dermatology : EJD 2011;21(1):32-6.
2010: Paolo Fava; Pietro Quaglino; Maria Teresa Fierro; Mauro Novelli; Maria Grazia Bernengo
Therapeutic hotline. A rare vandetanib-induced photo-allergic drug eruption.
Dermatologic therapy 2010;23(5):553-5.
2010: Maria Teresa Fierro; Renata Ponti; Stefano Titli; Lisa Bonello; Alessandra Comessatti; Mauro Novelli; Paolo Fava; Paola Francia di Celle; Pietro Quaglino; Maria Grazia Bernengo
TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome.
The Journal of investigative dermatology 2010;130(9):2312-9.
2010: Federica Marenco; Paolo Fava; Maria Teresa Fierro; Pietro Quaglino; Maria Grazia Bernengo
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease.
Dermatologic therapy 2010;23(4):419-22.
2010: Paola Savoia; Paolo Fava; Simona Osella-Abate; Tiziana Nardò; Alessandra Comessatti; Pietro Quaglino; Maria Grazia Bernengo
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre.
Melanoma research 2010;20(3):227-32.
2010: Emiliano Antiga; Pietro Quaglino; S Bellandi; Walter Volpi; Elena del Bianco; A Comessatti; S Osella-Abate; Clara De Simone; Angelo V Marzano; Maria Grazia Bernengo; Paolo Fabbri; Marzia Caproni
Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea.
The British journal of dermatology 2010;162(5):1056-63.
2010: Maria Teresa Fierro; Federica Marenco; Mauro Novelli; Paolo Fava; Pietro Quaglino; Maria Grazia Bernengo
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp.
The American Journal of dermatopathology 2010;32(1):91-4.
2010: Pietro Quaglino; F Marenco; Simona Osella-Abate; Nazario Cappello; Michela Ortoncelli; B Salomone; Maria Teresa Fierro; Paola Savoia; Maria Grazia Bernengo
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(2):409-14.
2009: Paola Savoia; Paolo Fava; Tiziana Nardò; Simona Osella-Abate; Pietro Quaglino; Maria Grazia Bernengo
Skin metastases of malignant melanoma: a clinical and prognostic survey.
Melanoma research 2009;19(5):321-6.
2009: Paola Savoia; Paolo Fava; Tommaso Deboli; Pietro Quaglino; Maria Grazia Bernengo
Zosteriform cutaneous metastases: a literature meta-analysis and a clinical report of three melanoma cases.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2009;35(9):1355-63.
2009: Federica Marenco; Paolo Fava; Giuseppe Macripò; Pietro Quaglino; Paola Savoia; Maria Grazia Bernengo
Cutaneous melanoma metastases arising on a split-skin graft donor site.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2009;35(8):1282-5.
2009: Mauro Novelli; Chiara Merlino; Renata Ponti; Massimiliano Bergallo; Pietro Quaglino; I Cambieri; Alessandra Comessatti; Sidoti Francesca; Cristina Costa; Daniele Corino; Rossana Cavallo; Alessandro Negro Ponzi; Maria Teresa Fierro; Maria Grazia Bernengo
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood.
The Journal of investigative dermatology 2009;129(6):1556-61.
2009: Pietro Quaglino; Alessandra Comessatti; Renata Ponti; A Peroni; F Mola; Maria Teresa Fierro; Paola Savoia; Mauro Novelli; Maria Grazia Bernengo
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.
International journal of immunopathology and pharmacology 2009;22(2):353-62.
2009: Pietro Quaglino; Michela Ortoncelli; Alessandra Comessatti; Renata Ponti; Mauro Novelli; M Bergallo; Cristina Costa; S Cicchelli; Paola Savoia; Maria Grazia Bernengo
Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients.
Dermatology (Basel, Switzerland) 2009;219(3):250-8.
2008: Pietro Quaglino; C Mortera; Simona Osella-Abate; M Barberis; M Illengo; M Rissone; Paola Savoia; Maria Grazia Bernengo
Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases.
Annals of surgical oncology 2008;15(8):2215-22.
2008: Renata Ponti; Maria Teresa Fierro; Pietro Quaglino; Bonello Lisa; Francia di Celle Paola; Ortoncelli Michela; Fava Paolo; Alessandra Comessatti; Mauro Novelli; Maria Grazia Bernengo
TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples.
The Journal of investigative dermatology 2008;128(4):1030-8.
2008: Paola Savoia; Simona Osella-Abate; Alessandra Comessatti; T Nardò; Caterina Marchiò; Donatella Pacchioni; Pietro Quaglino; Maria Grazia Bernengo
Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status.
Journal of clinical pathology 2008;61(2):179-83.
2008: Maria Teresa Fierro; Mauro Novelli; Pietro Quaglino; Alessandra Comessatti; P Fava; Michela Ortoncelli; Renata Ponti; Maria Grazia Bernengo
Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma.
Dermatology (Basel, Switzerland) 2008;216(3):213-21.
2008: Pietro Quaglino; Marzia Caproni; Simona Osella-Abate; Daniele Torchia; Alessandra Comessatti; Elena del Bianco; Emiliano Antiga; Alessandra Frezzolini; Donatella Schena; Angelo V Marzano; Clara De Simone; Aurora Parodi; Paolo Fabbri; Maria Grazia Bernengo
Serum interleukin-13 levels are increased in patients with Stevens-Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme.
The British journal of dermatology 2008;158(1):184-6.
2007: Angelo V Marzano; Alessandra Frezzolini; Marzia Caproni; Aurora Parodi; Daniele Fanoni; Pietro Quaglino; V Girgenti; Michelangelo La Placa; Paolo Fabbri; Ruggero Caputo; Emilio Berti
Immunohistochemical expression of apoptotic markers in drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.
International journal of immunopathology and pharmacology 2007;20(3):557-66.
2007: Maria Grazia Bernengo; Pietro Quaglino; Alessandra Comessatti; Michela Ortoncelli; Mauro Novelli; Francesco Lisa; Maria Teresa Fierro
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients.
Haematologica 2007;92(6):784-94.
2007: Pietro Quaglino; Simona Osella-Abate; Nazario Cappello; Michela Ortoncelli; Tiziana Nardò; Maria Teresa Fierro; Federica Cavallo; Paola Savoia; Maria Grazia Bernengo
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.
Melanoma research 2007;17(2):75-82.
2007: Pietro Quaglino; Simona Osella-Abate; Paola Savoia; Maria Grazia Bernengo; Nazario Cappello; Federica Cavallo
What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(9):1140-1; author reply 1141-2.
2007: Pietro Quaglino; Marzia Caproni; Emiliano Antiga; Elena del Bianco; Simona Osella-Abate; Paola Savoia; Alessandra Frezzolini; Donatella Schena; Angelo V Marzano; Walter Volpi; Clara De Simone; Aurora Parodi; Paolo Fabbri; Maria Grazia Bernengo
Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
Dermatology (Basel, Switzerland) 2007;214(4):296-304.
2006: Marzia Caproni; Daniele Torchia; Emiliano Schincaglia; Walter Volpi; Alessandra Frezzolini; Donatella Schena; Angelo V Marzano; Pietro Quaglino; Clara De Simone; Aurora Parodi; Emanuela Barletta; Paolo Fabbri
Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
The British journal of dermatology 2006;155(4):722-8.
2006: Paola Savoia; Michela Ortoncelli; Pietro Quaglino; Maria Grazia Bernengo
Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2006;32(8):1097-102.
2006: Marzia Caproni; Emiliano Antiga; Aurora Parodi; Donatella Schena; Angelo V Marzano; Pietro Quaglino; Clara De Simone; Michelangelo La Placa; Walter Volpi; E Del Biano; Paolo Fabbri
Elevated circulating CD40 ligand in patients with erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
The British journal of dermatology 2006;154(5):1006-7.
2006: Pier Luigi Zinzani; Pietro Quaglino; Nicola Pimpinelli; Emilio Berti; Gianandrea Baliva; Serena Rupoli; Maurizio Martelli; Mauro Alaibac; Giovanni Borroni; Sergio Chimenti; Renato Alterini; Lapo Alinari; Maria Teresa Fierro; Nazario Cappello; Alessandro Pileri; Davide Soligo; Marco Paulli; Stefano Pileri; Marco Santucci; Maria Grazia Bernengo
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1376-82.
2006: Marzia Caproni; Daniele Torchia; Emiliano Schincaglia; Walter Volpi; Alessandra Frezzolini; Donatella Schena; Angelo V Marzano; Pietro Quaglino; Clara De Simone; Aurora Parodi; Emanuela Barletta; Paolo Fabbri
The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
The British journal of dermatology 2006;154(2):319-24.
2006: Maria Teresa Fierro; Alessandra Comessatti; Pietro Quaglino; Michela Ortoncelli; Simona Osella-Abate; Renata Ponti; Mauro Novelli; Maria Grazia Bernengo
Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome.
Dermatology (Basel, Switzerland) 2006;213(4):284-92.
2005: Renata Ponti; Pietro Quaglino; Mauro Novelli; Maria Teresa Fierro; Alessandra Comessatti; A Peroni; Lisa Bonello; Maria Grazia Bernengo
T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
The British journal of dermatology 2005;153(3):565-73.
2005: Maria Teresa Fierro; Paola Savoia; Pietro Quaglino; Domenico Novero; Maria Grazia Bernengo
Disseminated Kaposi's sarcoma associated with idiopathic CD4+ lymphocytopenia and low dose steroid therapy.
Clinical and experimental dermatology 2005;30(4):395-7.
2005: Paola Savoia; Pietro Quaglino; Simona Osella-Abate; Alessandra Comessatti; T Nardò; Maria Grazia Bernengo
Tyrosinase mRNA RT-PCR analysis as an additional diagnostic tool for the identification of melanoma cells in biological fluid samples other than blood: a preliminary report.
The International journal of biological markers 2005;20(1):11-7.
2004: Pietro Quaglino; Paola Savoia; Simona Osella-Abate; Maria Grazia Bernengo
RT-PCR tyrosinase expression in the peripheral blood of melanoma patients.
Expert review of molecular diagnostics 2004;4(5):727-41.
2004: Pietro Quaglino; Paola Savoia; Maria Teresa Fierro; Simona Osella-Abate; Maria Grazia Bernengo
Clinical significance of sequential tyrosinase expression in the peripheral blood of disease-free melanoma patients: a review of literature data.
Melanoma research 2004;14(2):S17-9.
2004: Giuseppe Macripò; Pietro Quaglino; Virginia Caliendo; Anna Maria Ronco; Shoreh Soltani; Elena Giacone; Stefano Pau; Maria Teresa Fierro; Maria Grazia Bernengo
Sentinel lymph node dissection in stage I/II melanoma patients: surgical management and clinical follow-up study.
Melanoma research 2004;14(2):S9-12.
2004: Pietro Quaglino; Maria Teresa Fierro; G L Rossotto; Paola Savoia; Maria Grazia Bernengo
Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.
The British journal of dermatology 2004;150(2):327-36.
2003: Simona Osella-Abate; Paola Savoia; Pietro Quaglino; Maria Teresa Fierro; C Leporati; Michela Ortoncelli; Maria Grazia Bernengo
Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients.
British journal of cancer 2003;89(8):1457-62.
2003: Maria Teresa Fierro; Paola Savoia; Pietro Quaglino; Mauro Novelli; Manuela Barberis; Maria Grazia Bernengo
Systemic therapy with cyclophosphamide and anti-CD20 antibody (rituximab) in relapsed primary cutaneous B-cell lymphoma: a report of 7 cases.
Journal of the American Academy of Dermatology 2003;49(2):281-7.
2003: Mauro Novelli; Alessandra Comessati; Pietro Quaglino; Paola Savoia; Maria Teresa Fierro; Maria Grazia Bernengo
CD26 expression on cutaneous infiltrates from patients with cutaneous T-cell lymphoma (CTCL) CD26 in cutaneous T-cell lymphoma patients.
Advances in experimental medicine and biology 2003;524():223-34.
2002: Giorgina Barbara Piccoli; Marco Quaglia; Pietro Quaglino; Manuel Burdese; Francesca Bermond; Elisabetta Mezza; Alberto Jeantet; Giuseppe Paolo Segoloni
Acute digital gangrene in a long-term dialysis patient -- a diagnostic challenge.
Medical science monitor : international medical journal of experimental and clinical research 2002;8(11):CS83-9.
2002: Simona Osella-Abate; Pietro Quaglino; Paola Savoia; C Leporati; Alessandra Comessatti; Maria Grazia Bernengo
VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course.
Melanoma research 2002;12(4):325-34.
2002: Aurora Parodi; Marzia Caproni; Angelo V Marzano; Clara De Simone; Michelangelo La Placa; Pietro Quaglino; C Veller Fornasa; Cristina Zane; Mario Vaccaro; Manuela Papini; Paolo Fabbri; Alfredo Rebora
Dermatomyositis in 132 patients with different clinical subtypes: cutaneous signs, constitutional symptoms and circulating antibodies.
Acta dermato-venereologica 2002;82(1):48-51.
2001: Pietro Quaglino; Simona Osella-Abate; Mauro Novelli; Francesco Lisa; Alessandra Comessatti; Maria Grazia Bernengo
Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern.
European journal of dermatology : EJD 2001;11(6):560-3.
2001: Maria Teresa Fierro; Mauro Novelli; Paola Savoia; I Cambieri; Pietro Quaglino; Simona Osella-Abate; Maria Grazia Bernengo
CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients.
Journal of cutaneous pathology 2001;28(7):356-62.
2001: Maria Grazia Bernengo; Mauro Novelli; Pietro Quaglino; Francesco Lisa; Andrea de Matteis; Paola Savoia; Nazario Cappello; Maria Teresa Fierro
The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.
The British journal of dermatology 2001;144(1):125-35.
2001: Simona Osella-Abate; Alessandro Zaccagna; Paola Savoia; Pietro Quaglino; B Salomone; Maria Grazia Bernengo
Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy.
Journal of the American Academy of Dermatology 2001;44(1):40-7.
2000: Simona Osella-Abate; Paola Savoia; I Cambieri; B Salomone; Pietro Quaglino; Maria Grazia Bernengo
Role of RT-PCR tyrosinase detection in the monitoring of patients with advanced metastatic melanoma.
Melanoma research 2000;10(6):545-55.
2000: Maria Grazia Bernengo; Pietro Quaglino; Nazario Cappello; Francesco Lisa; Simona Osella-Abate; Maria Teresa Fierro
Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients.
Melanoma research 2000;10(1):55-65.
2000: B Salomone; Renata Ponti; Maria Rosa Gasco; Elena Ugazio; Pietro Quaglino; Simona Osella-Abate; Maria Grazia Bernengo
In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: evaluation of antiproliferative activity and apoptosis induction.
Clinical & experimental metastasis 2000;18(8):663-73.
1999: Pietro Quaglino; Alessandro Zaccagna; A Verrone; Fabrizio Dardano; Maria Grazia Bernengo
Mycosis fungoides in patients under 20 years of age: report of 7 cases, review of the literature and study of the clinical course.
Dermatology (Basel, Switzerland) 1999;199(1):8-14.
1998: Maria Teresa Fierro; Pietro Quaglino; Paola Savoia; A Verrone; Maria Grazia Bernengo
Systemic polychemotherapy in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 81 patients treated with COP or CHOP.
Leukemia & lymphoma 1998;31(5-6):583-8.
1998: Maria Grazia Bernengo; Pietro Quaglino; Mauro Novelli; Nazario Cappello; G C Doveil; Francesco Lisa; Andrea de Matteis; Maria Teresa Fierro; A Appino
Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(8):857-63.
1998: Paola Savoia; Pietro Quaglino; A Verrone; Maria Grazia Bernengo
Multiple primary melanomas: analysis of 49 cases.
Melanoma research 1998;8(4):361-6.
1998: Carlo Tomasini; Pietro Quaglino; Mauro Novelli; Maria Teresa Fierro
"Aleukemic" granulomatous leukemia cutis.
The American Journal of dermatopathology 1998;20(4):417-21.
1998: Pietro Quaglino; Carlo Tomasini; Mauro Novelli; S Colonna; Maria Grazia Bernengo
Immunohistologic findings and adhesion molecule pattern in primary pure cutaneous Rosai-Dorfman disease with xanthomatous features.
The American Journal of dermatopathology 1998;20(4):393-8.
1997: Paola Savoia; Maria Teresa Fierro; Mauro Novelli; Pietro Quaglino; A Verrone; Massimo Geuna; Maria Grazia Bernengo
CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease.
The British journal of dermatology 1997;137(6):966-71.
1997: Maria Teresa Fierro; G C Doveil; Pietro Quaglino; Paola Savoia; A Verrone; Maria Grazia Bernengo
Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.
Dermatology (Basel, Switzerland) 1997;194(3):268-72.
1996: Maria Grazia Bernengo; G C Doveil; Maria Tiziana Bertero; Pietro Quaglino; Maria Teresa Fierro; Paola Savoia; A Appino; S Colonna
Low-dose integrated chemoimmuno-hormonotherapy with cisplatin, subcutaneous interleukin-2, alpha-interferon and tamoxifen for advanced metastatic melanoma--a pilot study.
Melanoma research 1996;6(3):257-65.
1996: Mauro Novelli; Paola Savoia; Maria Teresa Fierro; A Verrone; Pietro Quaglino; Maria Grazia Bernengo
Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases.
The British journal of dermatology 1996;134(6):1052-6.
1995: G C Doveil; Maria Teresa Fierro; Mauro Novelli; A Appino; Maria Tiziana Bertero; Pietro Quaglino; Maria Grazia Bernengo
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance.
Dermatology (Basel, Switzerland) 1995;191(3):234-9.